Inactive Instrument

Labomar S.p.A. Stock Deutsche Boerse AG

6I7

IT0005421646

News in other languages: Labomar S.p.A.

23-09-19	Labomar ottiene certificazione B CORP insieme a Importfab e Welcare
23-09-19	Labomar S p A : Il Gruppo Labomar ottiene la certificazione B CORP™
23-09-07	Labomar S p A : CHARTERHOUSE AL FIANCO DI LABOMAR PER SUPPORTARE LE PROSSIME FASI DI CRESCITA
23-09-07	Labomar S p A : Charterhouse al fianco del fondatore di Labomar per supportare le prossime fasi di crescita dell’azienda
23-08-07	First Capital esce da Labomar e incassa EUR9 milioni

More news

Managers and Directors: Labomar S.p.A.

Manager	Title	Age	Since
Walter Bertin CEO	Chief Executive Officer	67	1998-11-26
Nicola TomasinI DFI	Director of Finance/CFO	-	2022-11-30
Claudio de Nadai IRC	Investor Relations Contact	61	2018-01-28

Director	Title	Age	Since
Walter Bertin CHM	Chairman	67	1998-11-26
Sabrina Gasparato BRD	Director/Board Member	56	2018-01-28
Lorenzo Zambon BRD	Director/Board Member	52	2020-09-14

More insiders

LABOMAR S.R.L. is an Italy-based company, which produces dietary supplements, in either solid format or as liquids. The Company's oral solid products include chewable tablets, swallable tablets, coated tablets, gastro-resistant tablets, time release tablets, micro tablets, hard plant or animal gelatine capsules, oro dispersible powders, and water dispersible powders. Its oral liquid products include syrups, hydroglyceric and hydroalcoholic suspensions, solutions, emulsions, and nanoemulsions. The Company serves companies operating in the medical information sector, in distribution channels in chemist and herbalists shops, retail stores of products for athletes and retail organization.

Employees

355

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

07-16	Labomar S.p.A. announced that it has received funding from Altamar CAM Partners S.L, Cleon Capital Advisors SL	CI
06-26	Altamar CAM Partners S.L agreed to acquire minority stake in Labomar S.p.A.	CI
25-10-01	Labomar S.p.A. acquired 97.85% stake in Pharmia Oy from CapMan Oyj and CapMan Buyout XI.	CI
24-08-05	Labomar S.p.A. acquired an unknown majority stake in Laboratorios Entema Sl.	CI
23-09-19	Labomar obtains B CORP certification together with Importfab and Welcare	AN
23-08-07	First Capital exits Labomar and cashes in EUR9 million	AN
23-08-06	LBM Next S.P.A. made a bid to acquire 4.9% stake in Labomar S.p.A. from First Capital S.p.A. for ?9 million.	CI
23-07-21	Europe opens flat; Recordati does well on Mib.	AN
23-07-20	Labomar's revenues grow by double digits in the first half of the year	AN
23-07-20	Mib up slightly, caution reigns in markets	AN
23-07-20	Weak start expected for European indexes	AN
23-07-19	Mib keeps afloat; Nexi closes as best	AN
23-07-04	Labomar board assesses congruous value of LBM Next's takeover bid	AN

23-09-19	Labomar S p A : GROUP ACHIEVES B CORP™ CERTIFICATION	PU
23-09-07	Labomar S p A : CHARTERHOUSE PARTNER OF LABOMAR TO SUPPORT NEXT GROWTH PHASES	PU
23-07-07	Labomar Scientific Service: the new service based on the experience of Labomar Research	PU
23-06-01	Labomar S p A : PARTNERSHIP WITH IMA ACTIVE CONTINUES AND RENEWED	PU
23-04-14	VOTED PRODUCT OF THE YEAR 2023: LABOMAR PRODUCTS AWARDED IN SPAIN	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LABOMAR S.P.A.	-.--%	-.--%	-	-	191M
ELI LILLY AND COMPANY	-0.01%	+1.24%	+63.06%	+120.55%	1,056B
JOHNSON & JOHNSON	-1.61%	-0.60%	+47.32%	+71.79%	655B
ABBVIE INC.	-1.12%	-0.72%	+17.98%	+76.63%	471B
ROCHE HOLDING AG	-1.72%	-4.06%	+36.39%	+39.47%	342B
NOVARTIS AG	-0.40%	+3.83%	+22.08%	+28.82%	277B
ASTRAZENECA PLC	-0.51%	-1.93%	+12.09%	+11.94%	257B
AMGEN INC.	+1.32%	+3.27%	+54.63%	+57.63%	226B
GILEAD SCIENCES, INC.	-0.61%	-0.91%	+34.33%	+101.87%	189B
NOVO NORDISK A/S	-0.24%	-2.76%	-28.41%	-60.92%	170B
Average	-0.17%	+0.81%	+28.83%	+49.75%	404.77B
Weighted average by Cap.	-0.05%	+0.81%	+38.91%	+70.52%

Labomar S.p.A. Stock Deutsche Boerse AG

Stocks

6I7

IT0005421646

Pharmaceuticals

Latest news: Labomar S.p.A.

Press Releases: Labomar S.p.A.

News in other languages: Labomar S.p.A.

Managers and Directors: Labomar S.p.A.

Other Pharmaceuticals

Company Profile